401 related articles for article (PubMed ID: 35349731)
1. Circulating microRNAs as predictive biomarkers of coronary artery diseases in type 2 diabetes patients.
Mahjoob G; Ahmadi Y; Fatima Rajani H; Khanbabaei N; Abolhasani S
J Clin Lab Anal; 2022 May; 36(5):e24380. PubMed ID: 35349731
[TBL] [Abstract][Full Text] [Related]
2. MicroRNAs as Biomarkers for Coronary Artery Disease Related to Type 2 Diabetes Mellitus-From Pathogenesis to Potential Clinical Application.
Szydełko J; Matyjaszek-Matuszek B
Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36614057
[TBL] [Abstract][Full Text] [Related]
3. Investigation of miR-26a-5p and miR-19a-3p expression levels in angiographically confirmed coronary artery disease.
Coban N; Erkan AF; Ozuynuk-Ertugrul AS; Ekici B
Acta Cardiol; 2023 Oct; 78(8):945-956. PubMed ID: 37376990
[TBL] [Abstract][Full Text] [Related]
4. Circulating MicroRNA-423-3p Improves the Prediction of Coronary Artery Disease in a General Population - Six-Year Follow-up Results From the China-Cardiovascular Disease Study.
Wang X; Dong Y; Fang T; Wang X; Chen L; Zheng C; Kang Y; Jiang L; You X; Gai S; Wang Z; Cao H
Circ J; 2020 Jun; 84(7):1155-1162. PubMed ID: 32404537
[TBL] [Abstract][Full Text] [Related]
5. Systematic review of microRNA biomarkers in acute coronary syndrome and stable coronary artery disease.
Kaur A; Mackin ST; Schlosser K; Wong FL; Elharram M; Delles C; Stewart DJ; Dayan N; Landry T; Pilote L
Cardiovasc Res; 2020 May; 116(6):1113-1124. PubMed ID: 31782762
[TBL] [Abstract][Full Text] [Related]
6. Identification of a circulating microRNAs biomarker panel for non-invasive diagnosis of coronary artery disease: case-control study.
Abdallah HY; Hassan R; Fareed A; Abdelgawad M; Mostafa SA; Mohammed EA
BMC Cardiovasc Disord; 2022 Jun; 22(1):286. PubMed ID: 35751015
[TBL] [Abstract][Full Text] [Related]
7. Identification of stress-related microRNA biomarkers in type 2 diabetes mellitus: A systematic review and meta-analysis.
Liang YZ; Li JJ; Xiao HB; He Y; Zhang L; Yan YX
J Diabetes; 2020 Sep; 12(9):633-644. PubMed ID: 29341487
[TBL] [Abstract][Full Text] [Related]
8. Alteration of circulating platelet-related and diabetes-related microRNAs in individuals with type 2 diabetes mellitus: a stepwise hypoglycaemic clamp study.
Eyileten C; Wicik Z; Keshwani D; Aziz F; Aberer F; Pferschy PN; Tripolt NJ; Sourij C; Prietl B; Prüller F; von Lewinski D; De Rosa S; Siller-Matula JM; Postula M; Sourij H
Cardiovasc Diabetol; 2022 May; 21(1):79. PubMed ID: 35596173
[TBL] [Abstract][Full Text] [Related]
9. Dysregulation of endothelial colony-forming cell function by a negative feedback loop of circulating miR-146a and -146b in cardiovascular disease patients.
Chang TY; Tsai WC; Huang TS; Su SH; Chang CY; Ma HY; Wu CH; Yang CY; Lin CH; Huang PH; Cheng CC; Cheng SM; Wang HW
PLoS One; 2017; 12(7):e0181562. PubMed ID: 28727754
[TBL] [Abstract][Full Text] [Related]
10. Circulating Extracellular miRNA Analysis in Patients with Stable CAD and Acute Coronary Syndromes.
Zhelankin AV; Stonogina DA; Vasiliev SV; Babalyan KA; Sharova EI; Doludin YV; Shchekochikhin DY; Generozov EV; Akselrod AS
Biomolecules; 2021 Jun; 11(7):. PubMed ID: 34209965
[TBL] [Abstract][Full Text] [Related]
11. Significance of circulating microRNAs in diabetes mellitus type 2 and platelet reactivity: bioinformatic analysis and review.
Pordzik J; Jakubik D; Jarosz-Popek J; Wicik Z; Eyileten C; De Rosa S; Indolfi C; Siller-Matula JM; Czajka P; Postula M
Cardiovasc Diabetol; 2019 Aug; 18(1):113. PubMed ID: 31470851
[TBL] [Abstract][Full Text] [Related]
12. Potential value of circulating microRNA-126 and microRNA-210 as biomarkers for type 2 diabetes with coronary artery disease.
Amr KS; Abdelmawgoud H; Ali ZY; Shehata S; Raslan HM
Br J Biomed Sci; 2018 Apr; 75(2):82-87. PubMed ID: 29452547
[TBL] [Abstract][Full Text] [Related]
13. Circulating microRNAs as clinically useful biomarkers for Type 2 Diabetes Mellitus: miRNomics from bench to bedside.
Grieco GE; Besharat ZM; Licata G; Fignani D; Brusco N; Nigi L; Formichi C; Po A; Sabato C; Dardano A; Natali A; Dotta F; Sebastiani G; Ferretti E
Transl Res; 2022 Sep; 247():137-157. PubMed ID: 35351622
[TBL] [Abstract][Full Text] [Related]
14. Clinical significance of circulating microRNAs as diagnostic biomarkers for coronary artery disease.
Zhang L; Zhang Y; Xue S; Ding H; Wang Y; Qi H; Wang Y; Zhu W; Li P
J Cell Mol Med; 2020 Jan; 24(1):1146-1150. PubMed ID: 31709737
[TBL] [Abstract][Full Text] [Related]
15. Circulating MicroRNAs as Novel Diagnostic Biomarkers for Very Early-onset (≤40 years) Coronary Artery Disease.
DU Y; Yang SH; Li S; Cui CJ; Zhang Y; Zhu CG; Guo YL; Wu NQ; Gao Y; Sun J; Dong Q; Liu G; Li JJ
Biomed Environ Sci; 2016 Aug; 29(8):545-554. PubMed ID: 27660218
[TBL] [Abstract][Full Text] [Related]
16. The association of plasma levels of miR-146a, miR-27a, miR-34a, and miR-149 with coronary artery disease.
Hosseinpor S; Khalvati B; Safari F; Mirzaei A; Hosseini E
Mol Biol Rep; 2022 May; 49(5):3559-3567. PubMed ID: 35553331
[TBL] [Abstract][Full Text] [Related]
17. Upregulation of Circulating Cardiomyocyte-Enriched miR-1 and miR-133 Associate with the Risk of Coronary Artery Disease in Type 2 Diabetes Patients and Serve as Potential Biomarkers.
Al-Muhtaresh HA; Salem AH; Al-Kafaji G
J Cardiovasc Transl Res; 2019 Aug; 12(4):347-357. PubMed ID: 30610670
[TBL] [Abstract][Full Text] [Related]
18. Circulating endothelium-enriched microRNA-126 as a potential biomarker for coronary artery disease in type 2 diabetes mellitus patients.
Al-Kafaji G; Al-Mahroos G; Abdulla Al-Muhtaresh H; Sabry MA; Abdul Razzak R; Salem AH
Biomarkers; 2017; 22(3-4):268-278. PubMed ID: 27321479
[TBL] [Abstract][Full Text] [Related]
19. Circulatory miR-133b and miR-21 as Novel Biomarkers in Early Prediction and Diagnosis of Coronary Artery Disease.
Kumar D; Narang R; Sreenivas V; Rastogi V; Bhatia J; Saluja D; Srivastava K
Genes (Basel); 2020 Feb; 11(2):. PubMed ID: 32033332
[TBL] [Abstract][Full Text] [Related]
20. MiR-223-3p and miR-122-5p as circulating biomarkers for plaque instability.
Singh S; de Ronde MWJ; Kok MGM; Beijk MA; De Winter RJ; van der Wal AC; Sondermeijer BM; Meijers JCM; Creemers EE; Pinto-Sietsma SJ
Open Heart; 2020 Jun; 7(1):. PubMed ID: 32487772
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
